Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

PXS 5338K

Next Previous
Drug Profile

PXS 5338K

Alternative Names: PXS-5338; PXS-5338K

Latest Information Update: 13 Dec 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Pharmaxis
  • Developer Synairgen; Syntara Limited
  • Class Antifibrotics; Antineoplastics; Pyrans; Small molecules
  • Mechanism of Action LOXL2 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • No development reported Cancer; Hepatic fibrosis; Non-alcoholic steatohepatitis; Pulmonary fibrosis; Renal fibrosis

Most Recent Events

  • 04 Dec 2023 Pharmaxis is now called Syntara Limited
  • 28 Jul 2021 No recent reports of development identified for phase-I development in Non-alcoholic-steatohepatitis(In volunteers) in Australia (PO, Capsule)
  • 28 Aug 2020 No recent reports of development identified for preclinical development in Hepatic-fibrosis in Australia (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top